文献速递头颈部肿瘤放疗

单侧质子束放射治疗口咽鳞状细胞癌对侧失败率低:质子协作组多机构前瞻性研究

Low contralateral failure rate with unilateral proton beam radiotherapy for oropharyngeal squamous cell carcinoma: A multi-institutional prospective study from the proton collaborative group.
PubMed 文献 · Radiother Oncol · 2023-11-02

该多机构前瞻性研究评估41例接受单侧质子束治疗的口咽鳞状细胞癌患者,中位剂量69.96 CGE,中位随访14.7个月,对侧颈部失败1例(2.4%),1年局部区域控制率88.9%,无≥4级毒性。

要点

  • 单侧质子束治疗口咽鳞癌对侧颈部失败率2.4%(1例)。
  • 8例(20%)发生≥3级吞咽困难(4例)或食管炎(4例),无≥4级毒性。
  • 剂量学分析显示光子计划对侧剂量更高:平均15.5 Gy vs 0.7 CGE。

核心结论

  • 本系列首次报告口咽鳞状细胞癌接受单侧质子束治疗的结果,对侧颈部失败率极低,与光子照射的失败率相当。

研究设计与样本

  • 评估质子协作组数据库中2015年至2020年间在12家机构接受质子束治疗的头颈部鳞状细胞癌患者,共纳入41例接受同侧质子束治疗的口咽鳞状细胞癌患者,并对5例进行剂量学分析。

主要发现

  • 41例患者中37%(15例)为复发疾病,63%(26例)为新诊断疾病;口咽部位包括扁桃体窝30例和舌根11例。
  • 中位剂量和生物等效剂量分别为69.96 CGE和84 Gy。
  • 8例(20%)患者发生至少1次3级吞咽困难(4例)或食管炎(4例),未报告≥4级毒性。
  • 对侧颈部失败1例(2.4%);1年局部区域控制率为88.9%,无远处转移生存率为95.5%(2例)。
  • 剂量学分析显示同侧II区颈部淋巴结区域剂量相似,而对侧剂量在光子计划中更高,平均为15.5 Gy和0.7 CGE,D5%为25.1 Gy和6.6 CGE。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Unilateral radiation therapy is appropriate for select patients with oropharyngeal squamous cell carcinoma (OPSCC). The use of proton beam therapy (PBT) in the unilateral setting decreases the dose to the contralateral neck and organs at risk. This study aims to evaluate contralateral recurrences in patients who received ipsilateral PBT. METHODS: We evaluated the Proton Collaborative Group database for patients treated with PBT for head and neck squamous cell carcinoma between the years 2015-2020 at 12 institutions. Dosimetric analysis was performed in five cases. RESULTS: Our analysis included 41 patients that received ipsilateral PBT with a mean follow-up of 14.7 months. 37% patients (n = 15) were treated for recurrent disease, and 63% (n = 26) were treated for de novo disease. Oropharyngeal sites included tonsillar fossa (n = 30) and base of tongue (n = 11). The median dose and BED delivered were 69.96 CGE and 84 Gy, respectively. Eight (20%) patients experienced at least one grade 3 dysphagia (n = 4) or esophagitis (n = 4) toxicity. No grade ≥ 4 toxicities were reported. There was one (2.4%) failure in the contralateral neck. The 1-year locoregional control was 88.9% and the freedom from distant metastasis was 95.5% (n = 2). The dosimetric analysis demonstrated similar ipsilateral level II cervical nodal region doses, whereas contralateral doses were higher with photon plans, mean: 15.5 Gy and 0.7CGE, D5%: 25.1 Gy and 6.6CGE. CONCLUSIONS: Our series is the first to report outcomes for patients with OPSCC receiving unilateral PBT. The contralateral neck failure rate was excellent and comparable to failure rates with photon irradiation.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Mumaw DA, Hazy AJ, Vayntraub A, et al. Low contralateral failure rate with unilateral proton beam radiotherapy for oropharyngeal squamous cell carcinoma: A multi-institutional prospective study from the proton collaborative group. Radiother Oncol. 2023. PMID: 37922991. doi:10.1016/j.radonc.2023.109977

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。